Abstract
Invention relates to methods for prognosing risk of development of ovarian cancer in women having adnexal tumor. The method provides for a measuring level of human epidydimis secretory protein 4 and creatinine in urine and calculation of their ratio. If the ratio is 1.34 or higher there is a high risk of development of ovarian cancer.
| Translated title of the contribution | Olnīcu vēža riska noteikšanas paņēmiens sievietēm ar veidojumu dzemdes piedēkļu rajonā |
|---|---|
| Original language | Latvian |
| Patent number | 14902 |
| IPC | G01N33/52 |
| Priority date | 29/04/14 |
| Filing date | 29/04/14 |
| Publication status | Published - 20 Feb 2015 |
Keywords*
- prognosing risk of development of ovarian cancer
Field of Science*
- 3.2 Clinical medicine
Patent expiration date
- 01.11.2020
